We would love to hear your thoughts about our site and services, please take our survey here.
A dividend of £0.4768 was received from IWEB today. I am now 5% up after receiving 2 dividends. This share is still paying 8% dividend base on today's share price of £22.70 and the last 4 dividends £1.85 (£0.4768+£0.4085+£0.4756+£0.4887) paid.
Target Price HK$34.31 - see https://pdf.dfcfw.com/pdf/H3_AP202403041625295271_1.pdf
Mar 2023, Target Price was HK$37.49 - see https://pdf.dfcfw.com/pdf/H3_AP202303021583957689_1.pdf
Mar 2022, Target Price was HK$73.25 - see https://pdf.dfcfw.com/pdf/H3_AP202203071551123207_1.PDF
Sep 2021, Target Price was HK$77.74 - see https://pdf.dfcfw.com/pdf/H3_AP202109171516738534_1.pdf
Posted by user unastubbs over at advfn: https://www.standard.co.uk/business/abrdn-boss-ceo-pay-bonus-funds-shareholders-customers-aberdeen-asset-management-standard-life-b1141743.html
After 1 year 9 months with 7 dividend reinvested I am finally sitting on a tiny 1% profit. Next ex-dividend date is 14/12/2023, payable on 29/12/2023. Current dividend yield is 8.76% at the current share price. I'll continue to hold but won't be re-investing the dividend as other companies such as M&G and Phoenix are paying 9%-10% dividends. Experts are divided as to whether a recession will hit us next year. My strategy is to buy high dividend (8%-10%) paying shares to live out any recession as well as holding some cash to take advantage of any drop in share price.
There is an article here about stocks picked from randomly throwing darts beating the "experts" : https://www.marketwatch.com/story/random-darts-beat-hedge-fund-stars-again-2019-06-26
This is beginning to look interesting. Very low daily trading. It has gone down from a peak of just over £26 this year to £23 now. Dividend seem to have gone up and changed from 1 distribution a year to 4. See https://www.markets.iweb-sharedealing.co.uk/etf-centre/details/LU0292096186/B4R5 . Last year's dividend dates also differ from this year's - see https://uk.advfn.com/stock-market/london/xgl-div100-sw-XGSD/share-news . Full list of companies in the index can be found on this page https://etf.dws.com/en-gb/LU0292096186-stoxx-global-select-dividend-100-swap-ucits-etf-1d/ .
After 1 years 3 months I have received 5 dividend payments. However, even with the dividends reinvested I am still 3.2% down. Hopefully the next dividend will be around 36p, same as last year's and with SP stays around this level I will eb breaking even! Blackrock still list the Russian assets in their spreadsheet but with a weighting of 0.0.
It doesn't look good when even the CFO is flogging half of the freebies he was given, having never fork out a penny of his own money buying HCM shares. No explanation on why he wanted to do that either. Management incompetent to the extreme!
Target price HKD 27 / £2.86 to HKD 30 / £3.17 - see https://guba-eastmoney-com.translate.goog/news%2Chk00013%2C1262453391.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp
amones - here it is, https://sc.hkexnews.hk/gb/di.hkex.com.hk/di/NSAllFormList.aspx?sa2=an&sid=344192&corpn=HUTCHMED+(China)+Ltd.&sd=29/08/2022&ed=29/11/2022&cid=0&sa1=cl&scsd=29%2f08%2f2022&sced=29%2f11%2f2022&sc=0013&src=MAIN&lang=EN&g_lang=en& . Mainly longs from The Capital Group. No change in shorts.
Yesterday, there was a release of a detailed 58 pages analyst report from a mainland China company, Soochow Securities, covering Hutchmed for the first time. Report in Chinese only - https://pdf.dfcfw.com/pdf/H3_AP202211281580616226_1.pdf . Recommendation is BUY. Oddly there was no price target but a market cap target for 2023 double that of yesterday's market cap.
Two mainland China securities companies issued their analyst report on Hutchmed. Average target price HKD 27.24 / £2.88.
https://guba-eastmoney-com.translate.goog/news%2Chk00013%2C1245854369.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
https://guba-eastmoney-com.translate.goog/news%2Chk00013%2C1251286540.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
Chinese newspaper articles talking about "capital winter" affecting quite a few pharmaceutical companies including Hutchmed:
https://guba-eastmoney-com.translate.goog/news%2Chk00013%2C1250689540.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
https://guba-eastmoney-com.translate.goog/news%2Chk00013%2C1250307361.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
Hong Kong stocks hit an 11-year low after historic Fed rate hike - see https://edition.cnn.com/2022/09/22/investing/global-markets-hang-seng-intl-hnk/index.html . The management will probably come out with another LTIP to help.